Skip to main content
Premium Trial:

Request an Annual Quote

Doug Fisher, Jeffrey Cossman

Precipio has elected Doug Fisher and Jeffrey Cossman to its board in order to fill existing vacancies. Fisher will serve on Precipio's audit committee and compensation committee. Cossman will serve on the company's compensation committee and will chair the nominating and corporate governance committee. 

Fisher is currently executive-in-resident at venture capital firm InterWest Partners, where he has worked since March 2009. He is also chief business officer at Sera Prognostics. Cossman is founder of the United States Diagnostic Standards, where he also served as CEO and chairman. Prior to that, he was CSO and a member of the board of The Critical Path Institute and as medical director of Gene Logic. 

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.